Ischemic Heart Disease -from Clinical Side-
1)Department of Cardiovascular Surgery, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan
2)Department of Cardiovascular Medicine, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan
Over 190,000 patients die each year in japan due to ischemic heart disease. For these patients, percutaneous coronary intervention (PCI) or coronary artery bypass graft (CABG) are done to improve the blood flow of coronary artery with stenosis. It would be better to prevent or mitigate the progress of atherosclerosis in these patients before requiring surgery. Recently, it has been reported that epicardial adipose tissue plays an important role in the progression of atherosclerosis and ischemic heart disease.
This review shows the recent trends about ischemic heart disease from the clinical perspective, including its' treatment, pathology and preventive measure.
๚ใๅใ๏ 2017; 13(4), 210-213
epicardial adipose tissue, ischemic heart disease, CABG, biodegradable device
Hirotsugu Kurobe, MD, PhD, Department of Cardiovascular Surgery, Graduate School of Biomedical Sciences, Tokushima University, 3-8-15 Kuramoto-chou, Tokushima-shi TOKUSHIMA 770-8503, JAPAN